BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Emodin

a laxative, but is now used mainly as a tool in toxicity studies.

300+ PubMed studies analyzed · Evidence Score: 38.1

Research Domains

Emodin has been studied across 20 research domains including 🔬 Oncology, 🔬 Inflammation, 🫁 Liver & Detox, ⚡ Energy & Fatigue, 🔥 Metabolic. The primary research focus is 🔬 Oncology with 32% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Emodin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Zearalenone
28 shared targets
Iodoacetamide
23 shared targets
Spironolactone
24 shared targets
myricetin-3-O-galactopyranoside
40 shared targets
Cisplatin
18 shared targets
Retinaldehyde
23 shared targets
Estrone
21 shared targets
Kaempferols
32 shared targets
tyrphostin
24 shared targets
Apigenin
41 shared targets
Loading evidence profile...

This evidence profile for Emodin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.